China Medical Systems gets SFDA approval for Phase II trial for cancer treatment

July 31, 2008

Debi wrote an interesting post today on
Here’s a quick excerpt
China Medical System Holdings Ltd. said it has received approval from the Chinese State Food and Drug Administration (SFDA) to begin the Phase II clinical trial for CMS024-02 (Tyroservatide), a drug for the treatment of non-small cell lung cancer.

var TFSMFlash_PRETAG=””; var TFSMFlash_POSTTAG=””; var TFSMFlash_VERSION=”8″; var TFSMFlash_WMODE=”window”; var TFSMFlash_OASCLICK=”http://oascentral.tradingmarkets.com/RealMedia/ads/click_lx.ads/www.tradingmarkets.com/L22/2025879575/Middle1/Trademkt/InterbankFX05-0708-300×250/300×250InterbankFX05-063008.html/7a386830793068727363494144775459″; var TFSMFlash_SWFCLICKVARIABLE=”?clickTAG=”+TFSMFlash_OASCLICK+”?http://ibfx.com/Accounts/OpenDemo.aspx?ibfx=TM04570732″; var TFSMFlash_SWFFILE=”http://imagec05.247realmedia.com/RealMedia/ads/Creatives/Trademkt/InterbankFX05-0708-300×250/IBFX_ToolsPRS300×2505L.swf/1216271331″+TFSMFlash_SWFCLICKVARIABLE; var TFSMFlash_FSCOMMAND=””; var TFSMFlash_IMAGEALTERNATE=””; var TFSMFlash_OASALTTEXT=””; var TFSMFlash_OASTARGET=”_blank”; var TFSMFlash_OASPROTOCOL=”http://”; var TFSMFlash_OASDIM=”WIDTH=’300′ HEIGHT=’250′”; var TFSMFlash_OASADID=”OAS_RMF_Middle1_FLASH”; document.write(’‘);

Read the rest of this great post here

Category Posted in Research